Tianwen J. Hu

1088 Chuansha Road
Chuansha, 201209, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNA.

Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNA.

Journal: ACS infectious diseases

Published: April 27, 2026

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

Journal: Journal of virology

Published: April 21, 2026

VV116 exerts potent efficacy against feline infectious peritonitis.

VV116 exerts potent efficacy against feline infectious peritonitis.

Journal: Veterinary microbiology

Published: March 05, 2026

Design, synthesis, and evaluation of novel tricyclononene carboxamide derivatives as dual anti-orthopoxvirus and anti-inflammatory agents.

Design, synthesis, and evaluation of novel tricyclononene carboxamide derivatives as dual anti-orthopoxvirus and anti-inflammatory agents.

Journal: Bioorganic & medicinal chemistry

Published: February 10, 2026

N-aryl-N-acyl diamine derivatives as novel selective serotonin/norepinephrine transporter inhibitors for the treatment of premature ejaculation.

N-aryl-N-acyl diamine derivatives as novel selective serotonin/norepinephrine transporter inhibitors for the treatment of premature ejaculation.

Journal: European journal of medicinal chemistry

Published: January 30, 2026

Deuremidevir hydrobromide (VV116) is a promising antiviral against human metapneumovirus.

Deuremidevir hydrobromide (VV116) is a promising antiviral against human metapneumovirus.

Journal: Virus research

Published: January 29, 2026

The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection.

The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection.

Journal: Emerging microbes & infections

Published: November 19, 2025

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

An orally available 4'-fluorouridine prodrug inhibits SFTSV and LCMV infection.

Journal: Journal of virology

Published: September 16, 2025

Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like properties.

Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like properties.

Journal: European journal of medicinal chemistry

Published: August 05, 2025

Identification of Cannabigerol-Derived Dual CB2 Receptor Agonists and TRPM8 Antagonists with Anti-Inflammatory and Analgesic Activities.

Identification of Cannabigerol-Derived Dual CB2 Receptor Agonists and TRPM8 Antagonists with Anti-Inflammatory and Analgesic Activities.

Journal: Journal of medicinal chemistry

Published: June 20, 2025

Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSV.

Design and Development of a Novel Oral 4'-Fluorouridine Double Prodrug VV261 against SFTSV.

Journal: Journal of medicinal chemistry

Published: April 28, 2025

Corrigendum to "D-morphinan analogs with favorable pharmacokinetic profiles as dual-acting antidepressants" [Europ. J. Med. Chem. 287 (2025) 117349].

Corrigendum to "D-morphinan analogs with favorable pharmacokinetic profiles as dual-acting antidepressants" [Europ. J. Med. Chem. 287 (2025) 117349].

Journal: European journal of medicinal chemistry

Published: March 06, 2025

Showing 1-12 of 25

Last Updated: 09/26/2026